JNS024 ER
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for JNS024 ER, covering 2014-01-15 to 2014-01-15. Get the full timeline:
Most recent: Clinical Trial Update: A Safety and Efficacy Study of JNS024 Extended Release (ER) in Japanese and Korean Patients With Chronic Malignant Tumor-Related Cancer Pain [Phase 3]